Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group

Autor: Morillon M.B., Christensen R., Singh J.A., Dalbeth N., Saag K., Taylor W.J., Neogi T., Kennedy M.A., Pedersen B.M., McCarthy G.M., Shea B., Diaz-Torne C., Tedeschi S.K., Grainger R., Abhishek A., Gaffo A., Nielsen S.M., Noerup A., Simon L.S., Lassere M., Tugwell P., Stamp L.K., Gout Working Group F.T.O.

Publikováno v: SEMINARS IN ARTHRITIS AND RHEUMATISM
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Serum urate (SU) is the most common primary efficacy outcome in trials of urate-lowering therapies for gout. Despite this, it is not formally considered a validated surrogate outcome. In this paper we will outline the definitions of biomarkers and su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2bb6681e0c89e1bf8fc2c2e08148547c
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8060

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases.

Autor: Kuwabara, Masanari¹ (AUTHOR) kuwamasa728@gmail.com, Fukuuchi, Tomoko² (AUTHOR) fukuuchi@pharm.teikyo-u.ac.jp, Aoki, Yuhei³ (AUTHOR) aokiyuhei127@gmail.com, Mizuta, Einosuke⁴ (AUTHOR) einytori@gmail.com, Ouchi, Motoshi^5,6 (AUTHOR) ouchi@dokkyomed.ac.jp, Kurajoh, Masafumi⁷ (AUTHOR) masafumi-kurajoh@omu.ac.jp, Maruhashi, Tatsuya⁸ (AUTHOR) 55maruchin@gmail.com, Tanaka, Atsushi⁹ (AUTHOR) tanakaa2@cc.saga-u.ac.jp, Morikawa, Nagisa^10,11 (AUTHOR) nagisa1981417@gmail.com, Nishimiya, Kensuke¹² (AUTHOR) kensuke118@cardio.med.tohoku.ac.jp, Akashi, Naoyuki¹³ (AUTHOR) noexcuse87@hotmail.com, Tanaka, Yoshihiro¹⁴ (AUTHOR) yoshi.tanaka0626@gmail.com, Otani, Naoyuki¹⁵ (AUTHOR) naoyuki@dokkyomed.ac.jp, Morita, Mihoko¹⁶ (AUTHOR) mtakai@u-fukui.ac.jp, Miyata, Hiroshi¹⁷ (AUTHOR) hmiyata924@gmail.com, Takada, Tappei¹⁷ (AUTHOR) tappei-tky@umin.ac.jp, Tsutani, Hiroshi¹⁸ (AUTHOR) tsutani.hiroshi.tq@mail.hosp.go.jp, Ogino, Kazuhide¹⁹ (AUTHOR) ko-36@umin.ac.jp, Ichida, Kimiyoshi²⁰ (AUTHOR) ichida@toyaku.ac.jp, Hisatome, Ichiro²¹ (AUTHOR) hisatome@med.tottori-u.ac.jp

Publikováno v: Biomolecules (2218-273X). Oct2023, Vol. 13 Issue 10, p1519. 25p.

Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review.

Autor: Tabi-Amponsah, Adwoa Dansoa¹ (AUTHOR) dansoa.tabi-amponsah@auckland.ac.nz, Stewart, Sarah² (AUTHOR) sarah.stewart@aut.ac.nz, Hosie, Graham¹ (AUTHOR), Stamp, Lisa K.³ (AUTHOR) lisa.stamp@cdhb.health.nz, Taylor, William J.⁴ (AUTHOR) william.taylor@otago.ac.nz, Dalbeth, Nicola¹ (AUTHOR) n.dalbeth@auckland.ac.nz

Publikováno v: Pharmaceuticals (14248247). Jun2023, Vol. 16 Issue 6, p779. 11p.